Therapeutic approaches to restore the expression of DKK1 in tumors, with subsequent reduction of up-regulated Wnt target genes, combined with a reduction of S100A4 expression, could improve the outcome of S100A4-driven CRC. This evidence concerns the gene DKK1 and colorectal carcinoma.